Brain 5-HT1 binding sites in depressed suicides - PubMed (original) (raw)

Brain 5-HT1 binding sites in depressed suicides

S C Cheetham et al. Psychopharmacology (Berl). 1990.

Abstract

5-HT1 and 5-HT1A binding sites were measured in brain tissue obtained at postmortem from 19 suicides, with definite evidence of depression, and 19 sex and age-matched controls. Thirteen of the depressed suicides had not been prescribed psychoactive drugs recently (drug-free suicides); six had been receiving antidepressant drugs, alone or in combination with other drugs (antidepressant-treated suicides). No significant differences were found in the number or affinity of 5-HT1 and 5-HT1A binding sites in frontal or temporal cortex between drug-free suicides and controls. The number of 5-HT1 sites was significantly lower (by 20%), affinity unaltered, in hippocampus and the affinity significantly lower (by 33%), number unaltered, in amygdala of drug-free suicides than controls. The number of 5-HT1 binding sites tended to be higher and the affinity lower in the antidepressant-treated compared to drug-free suicides, and significantly so in hippocampus. The present results, together with our previous studies, provide no evidence of altered cortical 5-HT markers in depressed suicides, but further emphasise abnormalities in the hippocampus.

PubMed Disclaimer

Cited by

Omega-3 fatty acid deficient male rats exhibit abnormal behavioral activation in the forced swim test following chronic fluoxetine treatment: association with altered 5-HT1A and alpha2A adrenergic receptor expression.
Able JA, Liu Y, Jandacek R, Rider T, Tso P, McNamara RK. Able JA, et al. J Psychiatr Res. 2014 Mar;50:42-50. doi: 10.1016/j.jpsychires.2013.11.008. Epub 2013 Dec 6. J Psychiatr Res. 2014. PMID: 24360505 Free PMC article.
Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities.
Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L. Lyons WE, et al. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15239-44. doi: 10.1073/pnas.96.26.15239. Proc Natl Acad Sci U S A. 1999. PMID: 10611369 Free PMC article.
A proteomic analysis of the ventral hippocampus of rats subjected to maternal separation and escitalopram treatment.
Marais L, Hattingh SM, Stein DJ, Daniels WM. Marais L, et al. Metab Brain Dis. 2009 Dec;24(4):569-86. doi: 10.1007/s11011-009-9156-3. Epub 2009 Oct 16. Metab Brain Dis. 2009. PMID: 19838779
Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
Klimek V, Zak-Knapik J, Mackowiak M. Klimek V, et al. J Psychiatry Neurosci. 1994 Jan;19(1):63-7. J Psychiatry Neurosci. 1994. PMID: 8148368 Free PMC article.
Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT.
Descarries L, Riad M. Descarries L, et al. Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2416-25. doi: 10.1098/rstb.2011.0361. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 22826342 Free PMC article. Review.

References

1. Brain Res. 1989 Nov 20;502(2):332-40 - PubMed
1. Psychiatry Res. 1980 Oct;3(2):225-36 - PubMed
1. Neuropharmacology. 1985 Dec;24(12):1187-94 - PubMed
1. J Neurochem. 1984 Dec;43(6):1699-705 - PubMed
1. Brain Res. 1988 Mar 8;443(1-2):272-80 - PubMed

Brain 5-HT1 binding sites in depressed suicides - PubMed (original) (raw)